Summary: August 29/October 24, 1984An enzymatic assay for the determination of the concentrations of various ß-lactam antibiotics in serum, urine, and cerebrospinal fluid samples is described. Recently developed ß-lactam derivatives are used äs competitive inhibitors of the breakdown of the labile coloured ß-lactam compound PADAC®, which serves äs the Substrate for the various ß-lactamases. Under the conditions of the assay, there is effectively no interference due to the matrix. Moreover, the assay is not influenced by other antibiotics such äs aminoglycosides, macrolides, ansamycines, tetracyclines, fusidic acid or fosfomycin. The C. V.s for within-run precision ranged from 3.7% to 4.4%, depending on the ß-lactam derivative. The sensitivity of the assay is at least comparable with that of conveiitional procedures. Excellent correlations were observed between the enzymatic and the nücrobiological procedures; correlation coefficients: r = 0.988 for 22 imipenem samples, r = 0.968 for 16 cefotaxime samples, and r = 0.989 for 16 piperacillin samples routinely sent to our laboratofy.
Introduction
At present concentrations of ß-lactam antibiotics are determined either by an agar diffusion test or by high Performance liquid chromatography (2) . As these methods are time-consuming and often require pretreatment of the samples, their routine use is restricted to experienced laboratories. The new methoxyiminocephalosporins are known to exhibit high affmity for the chromosomally mediated ß-lactamase from Enterobacter cloacae and can be considered competitive inhibitors. This suggested the possible enzymatic determination of cefotaxime concentrations (3, 4) : hydrolysis of the labile coloured cephalosporin compound PADAC® was competitively inhibited by cefotaxime, and the Inhibition of enzyme activity was related to the cefotaxime conĉ entration (4) . In a previous study it was demonstrated that most of the recently developed ß-lactam compounds exhibit high affinity to ß-lactamases and are fairly stable against breakdown by various enzymes. It seemed reasonable to explore the use of such an assay for the determination of a variety of therapeutically relevant compounds (5) . The enzymatic assay can be scheduled äs follows:
I. ß-lactam compound + ß-lactamase ^± [inactive complex] II. ß-lactamase (remaining) ^± hydrolysis of the substrate PADAC® (decrease in absorbance at 575 nm)
It had already been reported in the literature that PADAC® is well suited for this purpose, because there is no nonspecific cleavage of this compound by a biological matrix (3, 4) . In the present work, such an enzymatic assay for various ß-lactam compounds is described and compared with conventional procedures.
Material and Methods

Samples
All samples (serum, bile) investigated in this study were routinely sent to our laboratory and represented unselected clinical material. Bile samples (2 ml aliquots) were collected in tubes containing 0.4ml morpholine propane sulphonate (MOPS) buffer (0.1 mol/1) thus maintaining a final pH between 7.0 and 7.5 in the bile samples (6) . A pool serum was obtained from 10 healthy donors. Cerebrospinal fluid was pooled from 20 samples sent to our laboratory which revealed no bacteria when cultured. Urine samples were obtained from healthy persons who had not received antibiotic treatment within the previous 4 weeks. All samples were analysed either at once or kept frozen for a maximum of 14 days at -70°C.
Enzymes
The TEM-1 enzyme (a broad-spectrum, plasmid-mediated ß-lactamase) from E. coli K12 R6K was a commercially available preparation from Boehringer Mannheim (FRG 
Results
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The , -values for the enzymes employed and the chromogenic cephalosporin compound PADAC® are shown in tablel. It is evident that the chromogenic Tab. l. Properties of the ß-lactamases used for enzymatic determination of ß-lactam antibiotic concentrations. To rule out inferferences between the ß-lactamase employed and the sample matrix we investigated whether the sample matrix influences enzyme activity. The activity of each enzyme decreased when the amount of serum (or bile) exceeded a volume fraction of 0.10 of the total assay volume ( fig. 1 ). Similar fmdings were obtained for individual samples äs well äs for the pool serum. Urine and cerebrospinal fluid did not influence enzyme activity (data not shown).
With due regard for these conditions, the assay can be scheduled äs follows:
0.40 ml 0.05 mol/1 triethanolamine buffer containing the Substrate PADAC® in a final concentration of5 10" 5 mol/1, 0.02 ml sample and 0.02 ml enzyme solution; measure decrease in absorbance düring l or 2 niinutes at 575nm(25°C). Enzyme catalytic concentration was adjusted to a decrease of absorbance of A = 0.100/min. For the analysis of cerebrospinal fluid it may be useful to enhance the sensitivity of the assay; in these cases 0.05 ml sample volume can be used. Both ticarcillin and ceftazidime are known to react slowly with the Enterobacter cloacae and the Citrobacter freundii enzyme, respectively. Therefore a preincubation period of at least 2 minutes was maintained before monitoring the decrease of absorbance. the monobactam aztreonam) cannot be determined enzymatically either because they lack affmity for the enzymes, or they show non-competitive Inhibition of enzyme activity.
The assay remained unaffected by 100 mg/1 gentamicin, tetracycline, erythromycin, rifampicin, fusidic acid, fosfomycin, and the quinolone compound ofloxacin.
Combination of ß-lactam antibiotics
The enzymatic assay cannot be used for combinations of 2 ß-lactam compounds, when both are stable to hydrolysis by the enzyme employed, and both exhibit high affmity for the enzyme. Ampicillin and mezlocillin are used widely in combination with oxacillin. In this case oxacillin levels can be easily determined after pre-incubation with the enzyme from Proteus vulgaris, äs ampicillin and mezlocillin are rapidly inactivated ( fig. 3 ). For this purpose the assay has to be modified äs follows:
0.40 ml buffer containing the enzyme and 0.02 ml sample; mix and incubate (25°C or 37°C) for approximately 30 minutes; add 0.02ml Substrate solution (9.5 10" 4 mol/l PADAC®) and measure decrease in absorbance at 575 nm for l or 2 minutes.
As clavulanic acid exhibits time-dependent progressive Inhibition of enzyme activity after some minutes, this modified assay canript be used for the determination of clavulanic acid in the presence of ampicillin or amoxycillin ( fig. 3 ).
Within-run and day to day precision Within-run precision revealed C. V.s between 3.7 and 4.4% for all ß-lactam antibiotics. Day to day precision revealed a C. V. of 6.7% for cefotaxime.
Comparison of the enzymatic with the microbiological procedure A comparison of both pröcedures was performed for piperacillin, cefotaxime, and imipenem. There were good correlations between both procedufes for all three compounds: for imipenem r was 0. 
Discussion
In view of the reported occurrence of side effects from ß-lactam antibiotics, a rapid procedure for monitoring these compounds is needed. Above all, such an assay should be easy to perform and provide results within a few hours.
Our findings clearly deinonstrate that the enzymatic assay is äs sensitive äs the Standard procedures and requires only a small sample volume, which may be of advantage with respect to pediatric patients. The wide spread use of ß-lactam antibiotics in combination with aminoglycosides or macrolides is often associated with analytical problems; however, the enzymatic assay does not interfere with antibiotics other than ß-lactam compounds. The sensitivity of the enzymatic assay deserves special attention for the pharmacokinetic evaluation of new compounds exhibiting high affinity fof one of the various enzymes. Some compounds* such äs cefotaxime, are subject to metabolism, but the de-acetyl derivative does not affect the assay because of its lowered affinity to the enzyme (3). This aspect deserves attention, äs the de-acetyl derivative exhibits önly weak antibacterial activity (3).
It can be seen that the assay is of limited value for combinations of 2 ß-lactam antibiotics. In combinations of ampicillin or mezlocillin with pxacillin however, oxacillin concentrations can be determined with the Proteus vulgaris enzyme. This procedure is somewhat easier to handle than the microbiological procedure, which requires destruction of ampicillin prior to the assay.
The interaction of clavulanic acid with the Proteus vulgaris enzyme deserves further characterization. A mechanism related to that reported for the Escherichia coli TEM-1 enzyme may be assumed (9), i. e. the first Step of the interaction of clavulanic acid with the enzyme can be considered to be competitive, followed by a progressive irreversible inactivation of the enzyme.
The determination of imipenem by conventional procedures provides severe problems, because of the instäbility of the drug during storage and change of temperature. Thereföre, the enzymatic assay can be employed with advantage, thereby overcoming the slow nonspecific breakdown of this agent. This aspect deserves attention in the analysis of bile samples, because the imipenem is less stable at acidic or alkaline pH (8) , which explains the slight discrepancies between the enzymatic and the microbiological procedures.
At the moment interest is focused on the assay of imipenem, methoxy-imino cephalosporins, and lamoxactam. Unfortunately, lamoxactam lacks either binding or competitive Inhibition of the above ß-lactamases. With the characterization of further enzymes, assay procedures will become available for those compounds that cannot be assayed at present.
